Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 5.02, 9.01 · 8-K

V2X, Inc.

VVXNYSEEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation of L. Roger Mason, Jr. as Chief Growth Officer On August 7, 2026, Dr. L. Roger Mason, Jr. resigned from his position as: (i) Senior Vice President and Chief Growth Officer of V2X, Inc.…

Filed Aug 10, 2026Accepted Aug 10, 2026, 4:35 PM EDTCIK 1601548Accession 0001628280-26-055284
Share

Company context

Current securities

Recent company filings

  1. SCHEDULE 13G - filed by STATE STREET CORP regarding V2X, Inc.Nov 10, 2026
  2. S-3ASR filingNov 2, 2026
  3. Results of Operations and Financial ConditionNov 2, 2026
  4. 10-Q filingNov 2, 2026
  5. 4 filingAug 12, 2026

Registered securities in this filing

V2X, Inc. · 8-K · Filed 2026-08-10

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, Par Value $0.01 Per Share

Symbol
VVX
Exchange
NYSE
Classification
COMMON
Status
Current
Filing context

Context: c-1

Dimensions: Not supplied

Accession 000162828026055284 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 5.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation of L. Roger Mason, Jr. as Chief Growth Officer On August 7, 2026, Dr. L. Roger Mason, Jr. resigned from his position as: (i) Senior Vice President and Chief Growth Officer of V2X, Inc. (the “Company”) and (ii) all positions held for each direct and indirect subsidiary of the Company, each effective immediately, to serve as the Director of the National Reconnaissance Office of the U.S. Department of War. In anticipation of Dr. Mason’s resignation and in recognition for his contributions to the Company and for entering into a separation agreement and general release (the "Release Agreement"), dated August 6, 2026, with the Company, whereby Dr. Mason agreed to release all claims in favor of the Company, among other things, the Compensation and Human Capital Committee of the Board of Directors of the Company approved a payment to Dr. Mason in an amount of $331,975 (“AIP Payment”). The AIP Payment amount was equal to a prorated portion of his 2026 Annual Incentive Plan award at target based on the number of full months employed with the Company (from January 2026 through July 2026) prior to his confirmation as the Director of the National Reconnaissance Office of the U.S. Department of War. Dr. Mason’s resignation from the Company is not a result of any disagreement with the Company on any matter relating to its operations, policies or practices. Mr. Jeremy C. Wensinger, the Company’s Chief Executive Officer, will assume Dr. Mason’s role and responsibilities until such time as Dr. Mason’s successor has been appointed. The foregoing description of the Release Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Release Agreement, a copy of which is filed as Exhibit 10.1 hereto and incorporated herein by reference.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.